Biomanufacturing for both traditional biologics and new modalities, such as cell and gene therapies, continues to be an active area of investment for CDMOs/CMOS. Some of the major investments by the larger CMDOs/CMOs are outlined in this article.
The EU Green Deal sets a high bar for reducing greenhouse gas (GHG) emissions, and its impact will be felt across industries. But the chemical sector’s unique nature means that it will be more deeply affected than other industries – and more deeply involved in making net zero a reality, as well.
For its annual report "Value Creation in Chemicals 2021 – Ten Years of Steady Growth – and a Few Superstars," the strategy consultancy Boston Consulting Group examined the performance of leading international chemical companies from 2011 to 2020. The long-term perspective shows that the industry has mastered serious market downturns with astonishing confidence.
In March 2022, Mercator by Citco published a report that provides direct insights into the practice and dynamics of Global Entity Portfolio Management (GEPM) within the pharmaceuticals sector – based on real-life data – when these businesses have been at the epicenter of one of the most significant global disrupters in modern times.
Investment in UK biotech and life science companies scored a lifetime high in 2021, according to new data from the BioIndustry Association (BIA) and Clarivate.
In his interview with CHEManager, Jeff Zhu, chairman of the Chinese Association of International Chemical Manufacturers (AICM), talks about the industry’s role in helping achieve China’s carbon-neutrality goal.
Storage conditions play a vital role in the entire supply chain of pharmaceutical products and must comply with strict regulations. From manufacturers to patients, storage conditions are essential for the quality, safety, and efficacy of medications.
In the past 20 years, the chemical industry in China has grown rapidly and today accounts for close to 40% of worldwide chemical-industry revenue. Understanding environment-related regulatory and policy shifts now in full swing in China is critical to ensuring compliance and reducing business interruption risks for chemical companies either operating in or sourcing from China.
The positive impacts of Predictive Maintenance are broad and should be considered holistically. No one ever said that nurturing a perfect rose garden was simple, but the results can be dramatic.
The second part of the 2021 CPhI Annual Report looks ahead to predict the pharma manufacturing, therapeutic and technology environment in 2030.
Leading global chemical companies and the World Economic Forum (WEF) have announced that they are entering an agreement to formalize the Low-Carbon Emitting Technologies (LCET) initiative into a stand-alone entity by the end of 2023, to share early-stage risks and co-invest in developing and upscaling low-carbon emitting technologies.
Successfully managing the drug substance manufacturing of Antibody-Drug Conjugates (ADCs) requires a sophisticated understanding of the technological development process and access to a range of large- and small-molecule manufacturing assets.
The Processes4Planet (P4Planet) partnership’s goal is to transform the European process industries to make them circular and achieve overall climate neutrality at EU level by 2050, while enhancing their global competitiveness.
Industry experts Josef Trapl, Wolfgang Winter, Christian Woelbeling, and Thomas Zimmer – all members of ISPE’s Pharma 4.0 group – talk about the idea behind ISPE’s Pharma 4.0 initiative and the challenges on the way to realize the digital transformation of the pharmaceutical industry.
Over the past few years, sustainability has become a priority for innovation teams in the materials and chemicals industry as well as consumer-facing industries like apparel, food, and beauty.
On June 10th, 2021, ten leading German corporations announced the foundation of the Quantum Technology and Application Consortium (QUTAC). Boosted by the German Government, the goal of the newly founded consortium is to further develop the existing fundamentals of quantum computing into usable industrial applications.
The EU Commission’s ambitious plan for a European Green Deal, launched shortly before the pandemic struck in early 2020, aims to make the continent the world’s first climate-neutral region by 2050. The goals spelled out in January last year call for reduction of greenhouse gas emissions by at least 50% up to 2030, compared with 1990 levels.
Fernando J. Gómez, head of the Chemical and Advanced Materials Industry at the World Economic Forum (WEF), discusses the chemical-industry-related topics that are high on the WEF’s agenda.
How to Build or Maintain Critical Mass in the Chemical Distribution Industry
How to Build or Maintain Critical Mass in the Chemical Distribution Industry
How to Build or Maintain Critical Mass in the Chemical Distribution Industry
How to Build or Maintain Critical Mass in the Chemical Distribution Industry
How to Build or Maintain Critical Mass in the Chemical Distribution Industry
How to Build or Maintain Critical Mass in the Chemical Distribution Industry
How to Build or Maintain Critical Mass in the Chemical Distribution Industry
How to Build or Maintain Critical Mass in the Chemical Distribution Industry
How to Build or Maintain Critical Mass in the Chemical Distribution Industry
How to Build or Maintain Critical Mass in the Chemical Distribution Industry
Europe wants to become the world’s first climate-neutral continent by 2050 and decouple its economic growth from the consumption of natural resources – this is what the members of the European Union committed to in the so-called Green Deal in December 2019.
The CPhI executive post-pandemic pharma survey, produced by Informa Markets as part of the CPhI Pharma 2021 Report, predicts that pandemic supply chain issues have further cemented a push for repatriated manufacturing globally. The findings suggest that over the next 5 years, governments and companies will gradually look to reduce complexity and increase regional self-reliance.
Switzerland, as one of the leading global biotech hubs, was well positioned to facilitate international collaborations and develop solutions to combat the Covid-19 pandemic, and the sector saw record levels of investment in 2020. This is the bottom line of the latest edition of the Swiss Biotech Report, published by the Swiss Biotech Association in conjunction with EY and eight other partner organizations.
As Managing Director of Asahi Kasei Europe, Hideki Tsutsumi has implemented the Japanese chemical company's growth strategy in Europe.
CHEManager Interview with Antti Koivisto and Michael Badine, WeylChem Advanced Intermediates
To take advantage of the opportunity hydrogen presents, the European chemical industry must engage in the emerging hydrogen market now, setting up specific pilots, develop an appropriate partner and ecosystem network and, most crucially, adapt the R&D portfolios and investment plans needed to capture a share of the hydrogen opportunity.
The European Chemical Industry has set out on an ambitious path to become carbon neutral.
